SST and ACTH-producing pituitary gland adenoma: Considering the fact that current literature proves the expression of somatostatin and dopamine receptors in corticotroph adenoma tissues [2, 18, 19] and taking into account the result of the somatostatin receptor scintigraphy and postoperative tumour receptor SSRT 2A examination, the patient was administered 2 injections of long-acting release somatostatin analog (lanreotide 120 mg) at a 4-week interval and cabergoline (2 mg/week) for 8 weeks.